Car diac Conditions Clinical Pr actice Guidelin es – Nur sin g Assign m en t,
Car diac Phar m acology, and Peer Discussion Respon ses
, a. Describe your assigned client’s situation. Why are they presenting to
the clinic? What medications are they currently taking?
Tyrone Ball is a 72-year-old male who presents to the clinic for follow-
up one day after hospital discharge following percutaneous coronary
intervention (PCI) with placement of two stents for a ST-elevation
myocardial infarction (STEMI). During his inpatient stay, laboratory
results indicated well-controlled cholesterol levels and were otherwise
unremarkable. On physical examination, the PCI insertion site in the
right groin appears normal, with no signs of bleeding or hematoma.
His medical history includes transient ischemic attack (TIA),
hyperlipidemia, and hypertension. Tyrone is currently taking
atorvastatin 40mg orally daily, and diltiazem 120mg orally twice
daily. Other relevant information includes an allergy to aspirin, a
history of smoking cessation last year, and infrequent alcohol use
(approximately twice per year).
b. Assess the applicable clinical practice guideline (CPG) for your
assigned client linked on the same page in the lesson where the client
case is located. What treatment is recommended by the CPG for your
client’s situation?
Clinical practice guideline (CPG): 2023
AHA/ACC/ACCP/ASPC/NLA/PCNA Guideline for the
Management of Patients With Chronic Coronary Disease: A
Report of the American Heart Association/American College of
Cardiology Joint Committee on Clinical Practice Guidelines
The CPG recommends that patients with chronic coronary disease
(CCD) who undergo PCI with drug-eluting stent (DES) placement
should complete a 1- to 3-month course of dual antiplatelet therapy
(DAPT), followed by at least 12 months of P2Y12 inhibitor
monotherapy to help reduce the risk of bleeding (Virani et al., 2023).
c. Discuss your personal professional assessment of the client’s situation
provided in the scenario. What pharmacological treatment is
necessary and why?
Tyrone recently experienced a STEMI and underwent PCI with
placement of two stents. He is currently vitally stable, with laboratory
results indicating well-controlled cholesterol. Examination of the PCI
insertion site in the right groin reveals no signs of bleeding or
hematoma. His current medications will remain unchanged, as his
Car diac Phar m acology, and Peer Discussion Respon ses
, a. Describe your assigned client’s situation. Why are they presenting to
the clinic? What medications are they currently taking?
Tyrone Ball is a 72-year-old male who presents to the clinic for follow-
up one day after hospital discharge following percutaneous coronary
intervention (PCI) with placement of two stents for a ST-elevation
myocardial infarction (STEMI). During his inpatient stay, laboratory
results indicated well-controlled cholesterol levels and were otherwise
unremarkable. On physical examination, the PCI insertion site in the
right groin appears normal, with no signs of bleeding or hematoma.
His medical history includes transient ischemic attack (TIA),
hyperlipidemia, and hypertension. Tyrone is currently taking
atorvastatin 40mg orally daily, and diltiazem 120mg orally twice
daily. Other relevant information includes an allergy to aspirin, a
history of smoking cessation last year, and infrequent alcohol use
(approximately twice per year).
b. Assess the applicable clinical practice guideline (CPG) for your
assigned client linked on the same page in the lesson where the client
case is located. What treatment is recommended by the CPG for your
client’s situation?
Clinical practice guideline (CPG): 2023
AHA/ACC/ACCP/ASPC/NLA/PCNA Guideline for the
Management of Patients With Chronic Coronary Disease: A
Report of the American Heart Association/American College of
Cardiology Joint Committee on Clinical Practice Guidelines
The CPG recommends that patients with chronic coronary disease
(CCD) who undergo PCI with drug-eluting stent (DES) placement
should complete a 1- to 3-month course of dual antiplatelet therapy
(DAPT), followed by at least 12 months of P2Y12 inhibitor
monotherapy to help reduce the risk of bleeding (Virani et al., 2023).
c. Discuss your personal professional assessment of the client’s situation
provided in the scenario. What pharmacological treatment is
necessary and why?
Tyrone recently experienced a STEMI and underwent PCI with
placement of two stents. He is currently vitally stable, with laboratory
results indicating well-controlled cholesterol. Examination of the PCI
insertion site in the right groin reveals no signs of bleeding or
hematoma. His current medications will remain unchanged, as his
